Bayer Has a Headache

Bayer Stock Plunges

Bayer’s stock slumped more than 10 percent in trading Monday, three days after a California jury awarded $289 million to a former groundskeeper who said the popular weedkiller Roundup gave him terminal cancer. The stock drop sent a cautionary signal to the company that acquired Monsanto, the maker of the weedkiller, in June for $63 billion...

By | August, 14, 2018|Categories: Articles, Featured|Tags: , , , , , , , |0 Comments